Maintenance Rituximab Improves Outcomes in Mantle Cell Lymphoma Patients Who Respond to Induction Therapy with Bendamustine plus Rituximab without Autologous Transplant

被引：9

作者：

Hill, Brian T. ^{[1
]}

Switchenko, Jeffrey M. ^{[2
]}

Martin, Peter ^{[3
]}

Churnetski, Michael C. ^{[4
]}

Sawalha, Yazeed ^{[5
]}

Goyal, Subir ^{[2
]}

Shanmugasundaram, Krithika ^{[6
]}

Calzada, Oscar ^{[7
]}

Kolla, Bhaskar ^{[8
]}

Bachanova, Veronika ^{[8
]}

Gerson, James N. ^{[9
]}

Barta, Stefan K. ^{[9
]}

Gordon, Max J. ^{[10
]}

Danilov, Alexey ^{[11
]}

Grover, Natalie S. ^{[12
]}

Mathews, Stephanie ^{[13
]}

Burkart, Madelyn ^{[14
,15
]}

Karmali, Reem ^{[16
]}

Ghosh, Nilanjan ^{[17
]}

Park, Steven I. ^{[18
]}

Epperla, Narendranath ^{[19
]}

Bond, David A. ^{[20
]}

Badar, Talha ^{[21
]}

Blum, Kristie A. ^{[22
]}

Guo, Jin ^{[23
]}

Hamadani, Mehdi ^{[24
]}

Fenske, Timothy S. ^{[25
]}

Malecek, Mary-Kate ^{[26
]}

Kahl, Brad S. ^{[26
]}

Flowers, Christopher R. ^{[27
]}

Cohen, Jonathon B. ^{[28
]}

机构：

[1] Cleveland Clin Fdn, Taussig Canc Inst, Dept Hematol & Med Oncol, 9500 Euclid Ave, Cleveland, OH 44195 USA

[2] Emory Univ, Winship Canc Inst, Biostat & Bioinformat, Atlanta, GA 30322 USA

[3] Weill Cornell Med New York Presbyterian Hosp, New York, NY USA

[4] Emory Univ, Winship Canc Inst, Ctr Med, Atlanta, GA 30322 USA

[5] Cleveland Clin, Taussig Canc Inst, Dept Med & Hematol Oncol, Cleveland, OH 44106 USA

[6] Emory Univ, Sch Med, Atlanta, GA USA

[7] Emory Univ, Winship Canc Inst, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA

[8] Univ Minnesota, Div Hematol Oncol & Transplantat, Minneapolis, MN USA

[9] Univ Penn, Lymphoma Program, Abramson Canc Ctr, Philadelphia, PA 19104 USA

[10] Oregon Hlth & Sci Univ, Portland, OR 97201 USA

[11] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA

[12] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27515 USA

[13] Univ N Carolina, Chapel Hill, NC 27515 USA

[14] Northwestern Univ, Chicago, IL 60611 USA

[15] Northwestern Hosp, Robert H Lurie Comprehens Canc Ctr, Chicago, IL USA

[16] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA

[17] Atrium Hlth, Levine Canc Inst, Dept Hematol Oncol & Blood Disorders, Charlotte, NC USA

[18] Levine Canc Inst, Dept Hematol Oncol & Blood Disorders, Charlotte, NC USA

[19] Marshfield Clin Fdn Med Res & Educ, Columbus, OH USA

[20] Ohio State Univ Hosp, James Canc Ctr, Columbus, OH 43210 USA

[21] Med Coll Wisconsin, Milwaukee, WI 53226 USA

[22] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA

[23] Weill Cornell Med, Dept Med, New York, NY USA

[24] Med Coll Wisconsin, Milwaukee, WI 53226 USA

[25] Med Coll Wisconsin, Dept Med, Div Hematol Oncol, Milwaukee, WI 53226 USA

[26] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA

[27] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA

[28] Emory Univ, Atlanta, GA 30322 USA

来源：

BLOOD | 2019年 / 134卷

关键词：

D O I：

10.1182/blood-2019-129404

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1525

引用

页数：6

共 50 条

[21] Phase II Trial of Bortezomib Plus Rituximab As Maintenance Therapy Post ASCT for Patients with Mantle Cell Lymphoma
Chen, Robert W.
Palmer, Joycelynne M.
Popplewell, Leslie
Alluin, Jessica
Chomchan, Pritsana
Nademanee, Auayporn P.
Siddiqi, Tanya
Tsai, Nicole
Zuo, Fay
Abary, Rosie
Cai, Ji-lian
Rosen, Steven T.
Forman, Stephen J.
Kwak, Larry W.
Holmberg, Leona
BLOOD, 2017, 130
[22] Outcomes of Patients with Indolent Lymphoma Treated with Bendamustine Plus Rituximab Compared to Rituximab Plus CVP or CHOP Chemoimmunotherapy in Ontario
Suleman, Adam
Aktar, Suriya
Liu, Ning
Chan, Kelvin
Cheung, Matthew
Prica, Anca
BLOOD, 2021, 138
[23] Influence of rituximab plus bendamustine chemotherapy on the immune system in patients with refractory or relapsed follicular lymphoma and mantle cell lymphoma
Ito, Kaori
Okamoto, Masataka
Ando, Maiko
Kakumae, Yukiko
Okamoto, Akinao
Inaguma, Yoko
Tokuda, Masutaka
Yanada, Masamitsu
Yamada, Shigeki
Emi, Nobuhiko
LEUKEMIA & LYMPHOMA, 2015, 56 (04) : 1123 - 1125
[24] Ixazomib With or Without Rituximab Following Maintenance Autologous Stem Cell Transplant in Mantle Cell Lymphoma: A Single-Center Phase I Trial
Romancik, Jason T.
Chen, Zhengjia
Allen, Pamela B.
Waller, Edmund K.
Valla, Kelly
Colbert, Amanda
Rosand, Cecilia
Palmer, Alexandra F.
Flowers, Christopher R.
Cohen, Jonathon B.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 (12) : E1084 - E1091
[25] Bendamustine or high-dose cytarabine-based induction with rituximab in transplant-eligible mantle cell lymphoma
Villa, Diego
Hoster, Eva
Hermine, Olivier
Klapper, Wolfram
Szymczyk, Michal
Bosly, Andre
Unterhalt, Michael
Rimsza, Lisa M.
Ramsower, Colleen A.
Freeman, Ciara L.
Scott, David W.
Gerrie, Alina S.
Savage, Kerry J.
Sehn, Laurie H.
Dreyling, Martin
BLOOD ADVANCES, 2022, 6 (18) : 5285 - 5294
[26] RITUXIMAB MAINTENANCE THERAPY AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION PROLONGS PROGRESSION FREE SURVIVAL IN PATIENTS WITH MANTLE CELL LYMPHOMA
Dietrich, S.
Weidle, J.
Meissner, J.
Radujkovic, A.
Ho, A.
Dreger, P.
Witzens-Harig, M.
BONE MARROW TRANSPLANTATION, 2014, 49 : S180 - S181
[27] Rituximab Maintenance Therapy After Autologous Stem Cell Transplantation Prolongs Progression Free Survival In Patients With Mantle Cell Lymphoma
Dietrich, Sascha
Weidle, Julia
Meissner, Julia
Radujkovic, Aleksandar
Ho, Anthony D.
Dreger, Peter
Witzens-Harig, Mathias
BLOOD, 2013, 122 (21)
[28] Maintenance Rituximab after High-Dose Therapy and Autologous Stem Cell Transplantation in Mantle Cell Lymphoma
Roider, Tobias
Dietrich, Sascha
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (11) : 1811 - 1812
[29] Rituximab and Bendamustine (BR) Compared with Rituximab, Bendamustine, and Cytarabine (R-BAC) in Previously Untreated Elderly Patients with Mantle Cell Lymphoma
Bega, Giulia
Olivieri, Jacopo
Riva, Marcello
Scapinello, Greta
Paolini, Rossella
Finotto, Silvia
Sartori, Roberto
Lucchini, Elisa
Guandalini, Gianmarco
Facchinelli, Davide
Tisi, Maria Chiara
Basso, Marco
Ballotta, Laura
Piazza, Francesco
Ferrarini, Isacco
Visco, Carlo
CANCERS, 2021, 13 (23)
[30] Consolidation with Autologous Hematopoietic Cell Transplant in First Remission Improves Overall Survival in Younger Patients with Mantle Cell Lymphoma in the Rituximab Era
Gerson, James Nathan
Barta, Stefan Klaus
Villa, Diego
Gerrie, Alina S.
Li, Shaoying
Medeiros, Jeffrey
Wang, Michael
Hill, Brian T.
Sawalha, Yazeed
Hernandez-Ilizaliturri, Francisco J.
Kothari, Shalin
Vose, Julie M.
Fenske, Timothy S.
Rao, Swapna Narayana
Maddocks, Kami J.
Bond, David A.
Lansigan, Frederick
Burns, Timothy
Donovan, Alexandra M.
Mehta, Amitkumar
Reddy, Nishitha
Landsburg, Daniel J.
Glenn, Martha
Inwards, David James
Ristow, Kay
Karmali, Reem
Kaplan, Jason
Umyarova, Elvira
Pulluri, Bhargavi
Amengual, Jennifer E.
Lue, Jennifer Kimberly
Caimi, Paolo
Cohen, Jonathon B.
Calzada, Oscar
Handorf, Elizabeth
Anderson, Jennifer Kelly
Chapani, Parv
Bachanova, Veronika
Rajguru, Saurabh
Churnetski, Michael C.
Diefenbach, Catherine
Bast, Martin
Kovach, Alexandra E.
BLOOD, 2017, 130

← 1 2 3 4 5 →